A new study that aims to increase understanding of cell death in Parkinson’s has benefited from a £6 million (7 million euro) boost from the Innovative Medicines Initiative (IMI).
Results from a pioneering clinical trials programme that delivered an experimental treatment directly to the brain offer hope that it may be possible to restore the cells damaged in Parkinson’s.
A drug originally developed for prostate cancer may have exciting potential for treating Parkinson's, according to research published today in Cell Stem Cell.
The findings mark the launch of Parkinson's UK's campaign about freezing, a little-known symptom of Parkinson's that often strikes in crowded, public spaces.
A new study, published today in Science Translational Medicine, shows that Parkinson's may start in the appendix and an appendectomy lowers the risk of developing the neurological condition.
Chinese tech firm Tencent has teamed up with a London healthcare firm Medopad to develop artificial intelligence software that they hope will diagnose Parkinson's in minutes.